enterotrack

enterotrack

Innovative esophageal monitoring for EoE patients using non-invasive fluid biopsy technology.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

round
*

N/A

-
Total Funding000k
Notes (0)
More about enterotrack
Made with AI
Edit

EnteroTrack LLC specializes in providing a non-invasive solution for monitoring eosinophilic esophagitis (EoE) through its proprietary Esophageal String and EnteroTracker technology. This innovative approach allows physicians to easily and routinely collect mucosal fluid samples from the upper gastrointestinal tract of both adult and pediatric patients without the need for endoscopy or biopsy. The collected samples are then analyzed using a lab-developed test, with results promptly delivered back to the physician. EnteroTrack operates in the healthcare and medical device market, primarily serving physicians and patients dealing with EoE. The company's business model revolves around the sale of its Esophageal String device, which is available by prescription in the USA. Revenue is generated through the sale of these devices and associated lab testing services.

Keywords: EoE, esophageal monitoring, non-invasive, fluid biopsy, EnteroTracker, mucosal sampling, pediatric, adult, healthcare, medical device.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo